{"organizations": [], "uuid": "590ce1a3ccdb4e376f936c0628c4342bb17a58fc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180416.html", "section_title": "Archive News &amp; Video for Monday, 16 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-limflow-raises-27-mln-euros-in-fin/brief-limflow-raises-27-mln-euros-in-financing-led-by-sofinnova-partners-idUSFWN1RT0IE", "country": "US", "domain_rank": 408, "title": "BRIEF-LimFlow raises 27 mln euros in financing led by Sofinnova Partners", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.988, "site_type": "news", "published": "2018-04-16T20:07:00.000+03:00", "replies_count": 0, "uuid": "590ce1a3ccdb4e376f936c0628c4342bb17a58fc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-limflow-raises-27-mln-euros-in-fin/brief-limflow-raises-27-mln-euros-in-financing-led-by-sofinnova-partners-idUSFWN1RT0IE", "ord_in_thread": 0, "title": "BRIEF-LimFlow raises 27 mln euros in financing led by Sofinnova Partners", "locations": [], "entities": {"persons": [{"name": "martin rothman", "sentiment": "none"}, {"name": "balestier", "sentiment": "none"}, {"name": "limflow", "sentiment": "none"}], "locations": [{"name": "paris", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sofinnova partners", "sentiment": "negative"}, {"name": "md start", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 16 (Reuters) - LimFlow/Sofinnova Partners:\n* LimFlow, which develops innovative, peripheral endovascular technology transforming the treatment of critical limb ischemia (CLI), announced it has secured â‚¬27 million ($33.5 million) in an oversubscribed Series C financing.\n* The financing round was led by Sofinnova Partners, with continued participation from existing round B investors Bpifrance, the French sovereign investment bank, and Balestier, a Singaporean family fund.\n* Based in Paris, LimFlow was founded in late 2012 by Dr. Martin Rothman, a world-renowned interventional cardiologist, and MD Start, a European Incubator dedicated to healthcare, adds LimFlow in a statement\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-16T20:07:00.000+03:00", "crawled": "2018-04-17T12:25:07.110+03:00", "highlightTitle": ""}